Novartis / SPECIAL/SUBGROUP / Different Treatment Group / OTHER SPECIAL/SUBGROUP / ITT / /
Continent
Europe / /
Country
Switzerland / United States / Australia / /
Event
FDA Phase / /
IndustryTerm
pooled placebo control / imaging / /
MedicalCondition
chronic iron / FAS Beta-thalassemia / hereditary / Disease / FAS HbE beta-thalassemia / iron overload / chronic / thalassemia major / thalassemia / hemosiderosis / /
MedicalTreatment
chelation therapy / blood transfusions / /
Organization
U.S. Department of Health and Human Services / Standard Biometrics Division / Translational Sciences Office / Food and Drug Administration / FDA / Food and Drug Administration Center for Drug Evaluation / European Union / Research Office / Division of Hematology Products Clinical Team / /
Person
Mara Bauman Miller Keywords / Albert Deisseroth / Donna Przepiorka / Qing Xu / Thomas E Gwise / Mark Rothmann / /
Position
Deputy Director / DBV Medical Division / EXECUTIVE / Major / representative / Clinical Team Leader Project Manager / Statistical Team Leader / /
21882 Deferasirox Statistical PREA